LakeShore Property Plant And Equipment Gross from 2010 to 2025

LSBPW Stock   0.05  0  4.19%   
LakeShore Biopharma Property Plant And Equipment Gross yearly trend continues to be fairly stable with very little volatility. Property Plant And Equipment Gross will likely drop to about 755.9 M in 2025. During the period from 2010 to 2025, LakeShore Biopharma Property Plant And Equipment Gross regression line of quarterly data had mean square error of 13535.7 T and geometric mean of  509,718,514. View All Fundamentals
 
Property Plant And Equipment Gross  
First Reported
2010-12-31
Previous Quarter
915.7 M
Current Value
755.9 M
Quarterly Volatility
187.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check LakeShore Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LakeShore Biopharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 37.9 M, Interest Expense of 29.6 M or Selling General Administrative of 130.7 M, as well as many indicators such as Price To Sales Ratio of 10.68, Dividend Yield of 0.0 or PTB Ratio of 10.46. LakeShore financial statements analysis is a perfect complement when working with LakeShore Biopharma Valuation or Volatility modules.
  
Check out the analysis of LakeShore Biopharma Correlation against competitors.

Latest LakeShore Biopharma's Property Plant And Equipment Gross Growth Pattern

Below is the plot of the Property Plant And Equipment Gross of LakeShore Biopharma Co, over the last few years. It is LakeShore Biopharma's Property Plant And Equipment Gross historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LakeShore Biopharma's overall financial position and show how it may be relating to other accounts over time.
Property Plant And Equipment Gross10 Years Trend
Slightly volatile
   Property Plant And Equipment Gross   
       Timeline  

LakeShore Property Plant And Equipment Gross Regression Statistics

Arithmetic Mean536,011,607
Geometric Mean509,718,514
Coefficient Of Variation35.04
Mean Deviation165,605,151
Median415,571,497
Standard Deviation187,796,746
Sample Variance35267.6T
Range500.2M
R-Value0.80
Mean Square Error13535.7T
R-Squared0.64
Significance0.0002
Slope31,600,215
Total Sum of Squares529014.3T

LakeShore Property Plant And Equipment Gross History

2025755.9 M
2024915.7 M
2023796.3 M
2022791.6 M
2021745.3 M

About LakeShore Biopharma Financial Statements

LakeShore Biopharma investors use historical fundamental indicators, such as LakeShore Biopharma's Property Plant And Equipment Gross, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LakeShore Biopharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Property Plant And Equipment Gross915.7 M755.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for LakeShore Stock Analysis

When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.